GlassScriptPhysician profile
Tracey R Ikerd
NPI 1871532234
$39,407.03
in general payments reported to CMS, 2019-2025
34 companies · $3,546 in 2025
The $3,546 reported for 2025 was more than what 89% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,151 · 2020: $3,679 · 2021: $7,023 · 2022: $8,450 · 2023: $6,066 · 2024: $5,493 · 2025: $3,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $3,998 · Grant: $450 · Travel and Lodging: $116 · Education: $39.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,500.00 |
| Food and Beverage | $3,998.41 |
| Grant | $450.00 |
| Travel and Lodging | $116.16 |
| Education | $39.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $25,531.09 | 2021-2025 | |
| Allergan, INC. | $7,254.99 | 2019-2020 | |
| Organogenesis INC. | $1,694.76 | 2019-2025 | Puraply, Apligraf, Nushield |
| Merz North America, INC. | $937.25 | 2019-2023 | Xeomin |
| La Jolla Pharmaceutical Company | $548.67 | 2021-2025 | Zevtera, Xacduro, Xerava |
| Urgo Medical North America, LLC | $528.36 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Smith+Nephew, INC. | $423.88 | 2022-2025 | Grafix Pl, Oasis, Collagenase Santyl |
| Kerecis Limited | $264.34 | 2021-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Paratek Pharmaceuticals, INC. | $196.10 | 2023-2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $150.15 | 2019 | |
| Stryker Corporation | $147.39 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tetraphase Pharmaceuticals, INC. | $146.34 | 2019 | |
| Integra Lifesciences Corporation | $143.61 | 2019-2021 | |
| Janssen Biotech, INC. | $138.37 | 2019 | |
| Cardiovascular Systems INC. | $135.68 | 2023 | Diamondback Peripheral |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $125.00 | 2021 | |
| Convatec INC. | $124.41 | 2023 | |
| Tactile Systems Technology INC | $124.19 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Angiodynamics, INC. | $121.34 | 2021 | |
| Viiv Healthcare Company | $105.90 | 2019 | |
| Janssen Products, LP | $102.00 | 2019 | |
| Revance Therapeutics, INC. | $66.72 | 2025 | Daxxify |
| Melinta Therapeutics, LLC | $61.08 | 2019-2023 | Rezzayo, Kimyrsa, Vabomere |
| Insmed, INC. | $56.30 | 2019-2025 | Arikayce |
| Gilead Sciences, INC. | $54.32 | 2019 | |
| Terumo Medical Corporation | $52.75 | 2023 | Navicross, Tr Band, Angio-Seal |
| Mayne Pharma Commercial LLC | $34.71 | 2019 | |
| Theratechnologies INC. | $32.35 | 2019 | |
| Invivyd INC | $24.58 | 2024 | Pemgarda |
| Solventum Corporation | $20.17 | 2024 | Activ.A.C. |
| Mimedx Group, INC. | $18.91 | 2025 | |
| Csl Behring | $14.30 | 2019 | |
| Emd Serono, INC. | $14.13 | 2019 | |
| Osiris Therapeutics INC. | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Ikerd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.